raw silk are used for textiles, the sericin is mostly removed from the cocoon and disposed of unused. However, sericin has recently been investigated for its activities in biotechnological fields. It has been reported that sericin enhances the attachment and growth of mouse and human fibroblasts 14, 15 . Terada et al. found growth promotion in several human cell lines and mouse hybridomas when sericin was added to the culture media 16 . We also reported that isotonic solutions of sericin are stable, and that sericin instillation has a potent effect in promoting wound healing and wound-size reduction in rats 17 . In addition, sericin has protective effects against freezing stress in Escherichia coli 18 , and acts as an antioxidant to inhibit tyrosinase and lipid peroxidation 13 . In this study, we investigated the protective effects of sericin on BAC-induced corneal damage using rat debrided corneal epithelium and a human cornea epithelial cell line HCE-T .
In addition, we demonstrate the usefulness of a new preservative system for timolol maleate TM eye drops consisting of BAC and sericin.
EXPERIMENTAL

Animals and regents
Male Wistar rats and rabbits were housed under standard conditions 12 h/d fluorescent light 07:00-19:00 , 25 room temperature , and allowed free access to a commercial diet CE-2 or CR-3, Clea Japan Inc., Tokyo, Japan and water. All procedures were performed in accordance with the Kinki University School of Pharmacy Committee Guidelines for the Care and Use of Laboratory Animals and the Association for Research in Vision and Ophthalmology resolution on the use of animals in research. Pure Sericin TM 30 kDa was kindly donated by Seiren Co., Ltd. Fukui, Japan . Commercially available 0. 5 TM eye drops Timoptol ® and 0.4 Benoxil were obtained from Santen Pharmaceutical Co., Ltd. Osaka, Japan , and BAC was purchased from Kanto Chemical Co., Inc. Tokyo, Japan .
Escherichia coli E. coli, ATCC 8739 was provided by the National Institute of Technology and Evaluation Tokyo, Japan . All other chemicals used were of the highest purity commercially available.
2.2 Preparation of BAC solution and commercially available TM eye drops with or without sericin Sericin and BAC were each dissolved in saline and used to prepare BAC solutions with or without sericin, which were then filtered through a Minisart CE pore size of 0.20 μm, Costar, MA, USA . No adsorption of sericin or BAC to the filter was observed. The BAC eye drop with or without sericin were adjusted to pH 7.0 by the addition of 1N NaOH solution. For the preparation of commercially available TM eye drops with or without 0.1 sericin, 0.04 ml of filtrated saline or 5 sericin solution was added to 1.96 ml of commercially available TM eye drops. BAC concentrations used were determined according to the generally used range in many ophthalmic solution products; 0.01 -0.1 sericin solutions were used in this study.
Instillation of eye drops in rats
Ten microliters of saline, BAC or commercially available TM eye drops were instilled into the eyes of rats subjected to corneal abrasion next section five times per day 9:00, 12:00, 15:00, 18:00 and 21:00 . The eyes were kept open for approximately 1 min following instillation to prevent the eye drops from washing out.
Image analysis of corneal wound healing in rats
Rats, 7 weeks of age, were anesthetized with pentobarbital 30 mg/kg, i.p. , and a patch of corneal epithelium was removed with a BD Micro-Sharp TM blade 3.5 mm, 30 , Becton Dickinson, Fukushima, Japan as described previously 17, 19 . Cell viability Abs treatment /Abs non-treatment 100 3
2.6 Antimicrobial activity of BAC with or without sericin BAC solutions with or without 0.1 sericin were tested for antimicrobial activity against E. coli ATCC 8739 . The organism was selected based on Japanese Pharmacopoeia JP test protocols 22 . According to the standard methodology, the bulk dilution was split into 10 mL aliquots, which were inoculated with between 10 5 and 10 6 colony-forming units CFU /mL of E. coli ATCC 8739 1 organism per aliquot and incubated in the presence of saline, sericin or BAC solution with or without 0.1 sericin at 20 to 25 . Sampling and enumeration of the inoculated samples were done at 2, 7, 14 and 28 days. One mL aliquots were serially diluted in phosphate buffer, plated in duplicate on soybeancasein digest agar Casein soya bean digest agar for JP general test, Wako, Osaka, Japan , and incubated at 31 for 3 days. Raw data counts were converted to log CFU values. Since the samples were diluted at least 1:10 at the time of testing, 10 CFU reduction is the lowest sensitivity allowed by the test.
2.7
In vitro transcorneal penetration of TM from commercially available TM eye drops with or without sericin The in vitro transcorneal penetration of commercially available TM eye drops with or without 0.1 sericin was examined using the method of Iwata et al. 23 Adult Japanese albino rabbits weighing 2.5 to 3.0 kg were killed by injecting a lethal dose of pentobarbital into the marginal ear vein. The eyes were removed and the corneas were carefully separated from other ocular tissues. The individual corneas were placed on a methacrylate cell designed for transcorneal penetration studies. The side of the chamber donor chamber exposed to the exterior surface of the cornea was filled with commercially available TM eye drops with or without 0.1 sericin. The other side of the chamber reservoir chamber was filled with 10 mM HEPES buffer pH 7.4 containing 136.2 mM NaCl, 5.3 mM KCl, 1.0 mM K 2 HPO 4 , 1.7 mM CaCl 2 and 5.5 mM glucose. The experiments were performed at 35 for 6 h. Fifty microliters of sample solution was withdrawn from the reservoir chamber at the indicated time intervals and replaced with the same volume of buffer. TM concentration in the samples was determined by the following HPLC method. Fifty microliters of filtrate was added to 50 μL methanol containing 10 μg propyl p-hydroxybenzoate internal standard , and the mixture solution were filtered through a Chromatodisk 4A pore size 0.45 μm, Kurabo Industries Ltd., Osaka, Japan . The solution 10 μL was injected onto a Mightysil RP-18 3 μm, column size: 2.0 mm 50 mm column Kanto Chemical Co., Inc., Tokyo, Japan using a Shimadzu LC-10AD system equipped with a column oven CTO-6A Shimadzu Corp., Kyoto, Japan . The mobile phase consisted of 25 mM phosphate buffer pH 7 containing 30 methanol and 10 acetonitrile at a flow rate of 0.2 mL/min, the column temperature was 35 , and the wavelength for detection was 294 nm. Corneal viability was monitored by measuring thickness 0.0625 cm, average for 5 rabbits, no significant changes in thickness were observed over the 6 h period . The obtained data were analyzed by following equations:
where J c is the TM penetration rate, K m is the cornea/preparation partition coefficient, D is the diffusion constant within the cornea, C TM is the TM content in the ophthalmic preparation, τ is the lag time, δ is thickness of the cornea, Q t is the total amount of TM appearing in the reservoir solution at time t, and A is the effective area of the cornea 0.78 cm 2 . J c and τ were estimated by fitting each penetration profile to Eq. 6. The penetration coefficient through the cornea, K p , is given by J c /C TM . A nonlinear least-squares computer program was employed for the calculation 24 .
Measurement of intraocular pressure in rabbits
Intraocular pressure IOP enhancement in rabbits was induced by keeping them in a darkroom for 5 h 11:00 16:00 24 . A calibrated tonometer TonoPen XL Medtronic SOLAN, FL, USA was used to monitor the IOP after surface anesthesia 0. 
Briefly, AUC was determined according to the trapezoidal rule up to the last IOP measurement point.
Statistical analysis
All values are presented as mean standard error of the mean S.E. . Unpaired Student s t-test was used to evaluate statistical differences, and multiple groups were evaluated by one-way analysis of variance followed by Dunnett s multiple comparison. P values less than 0.05 were considered significant.
RESULTS
Preventive effects of sericin on the stimulation of BAC
in the cornea Figure 1 shows corneal wound healing levels following the instillation of BAC solutions with or without sericin. Table 1 shows the rate constants k H for corneal wound healing of rat eyes treated by the instillation of BAC solutions with or without sericin. The levels of corneal wound healing of rat eyes instilled with saline were approximately 51.4 at 12 h, and 86.2 at 24 h after corneal epithelial abrasion. The corneal wounds of rat eyes instilled with saline were almost entirely healed 36 h after corneal epithelial abrasion 99. 6 . The corneal wounds of rat eyes instilled with 0.02 BAC solutions showed 6.5 healing while those instilled with 0.02 BAC solutions containing 0.1 sericin showed 34.8 healing 12 h after corneal epithelial abrasion. The k H for rat eyes instilled with BAC with sericin was significantly higher than that of eyes instilled with BAC solutions without sericin Table 1 . Figure 2 shows the changes in cell viability of HCE-T cells following treatment with BAC solutions containing 0.01 -0.1 sericin. The cell viabilities of HCE-T cells treated with BAC solution for 10 or 20 sec were approximately 26.9 or 4.1 , respectively. On the other hand, the cell viability of HCE-T cells treated with BAC solutions containing sericin were higher than in the absence of sericin, and the cell viability of HCE-T cells increased with increasing sericin concentration. Figure 3 shows the antimicrobial activity of 0.005 BAC solution with or without 0.1 sericin. No antimicrobial activity was observed by the addition of saline and 0.1 sericin. The 0.005 BAC solution with 0.1 sericin showed high antimicrobial activity approximately equal to that of BAC solution without sericin. Table 2 summarizes the pharmacokinetic parameters calculated from the data for corneal healing Fig. 4 , in vitro transcorneal penetration and change of IOP. Figure 4 shows corneal wound healing levels following the instillation of commercially available TM eye drops with or without sericin. The k H for rat eyes instilled with TM eye drops containing sericin was significantly higher than that of eyes instilled with TM eye drops without sericin Table  2 , and the levels of corneal wound healing of rat eyes in- . Solutions were instilled into the eyes of rats five times a day following corneal abrasion. The data are presented as means S.E. of 4-10 independent rat corneas. *P < 0.05, vs. BAC solution without sericin for each category.
Effects of sericin on stimulation, transcorneal penetration and IOP of TM eye drops
stilled with TM eye drops with and without sericin were approximately 79.3 and 65.8 , respectively, 24 h after corneal epithelial abrasion. In the in vitro transcorneal penetration experiments, the amount of penetrated TM increased linearly for 6 h after the addition of TM eye drops with or without 0.1 sericin into the donor chambers, and there were no significant differences in the amount of penetration between the two eye drop formulations with or without 0.1 sericin, Table 2 . On the other hand, the IOP enhancement in rabbits was induced by keeping them in a darkroom; after 5 h in the dark, the IOP of rabbits rose by 7.1-9.6 mmHg as compared with untreated rabbits 16.5 mmHg . TM eye drops containing 0.1 sericin reduced the enhanced IOP, and the IOP reducing effects of TM eye drops both with and without sericin were similar Raw data counts were converted to log 10 values, and are presented as means ± S.E. of 5 independent experiments. Parameters were calculated according to equations 2, 4-6, and 7 (see EXPERIMENTAL). The data are presented as means S.E. of 5-6 independent rats or rabbits. *P < 0.05, vs. commercially available TM eye drops without sericin for each category. Commercially available TM eye drops with or without 0.1% sericin were instilled into rat eyes five times per day. The data are presented as means ± S.E. of 5-6 independent rat corneas. *P < 0.05, vs. commercially available TM eye drop-instilled rat eyes.
DISCUSSION
Damage to the cornea can result in scarring or opacification, causing visual defects that compromise transparency, and that can even lead to a complete loss of vision. Clinically, a delay in corneal wound healing caused by anti-glaucoma drugs is a serious problem for glaucoma patients. It has been reported that the main toxic effects of anti-glaucoma agents are related to the doses of the preservatives commonly used in eye-drop formulations 9, 10, 25 , the most common of which in ophthalmic preparations is BAC. In this study, we investigated the preventive effects of sericin on corneal damage by BAC using rat debrided corneal epithelium and HCE-T cells. In addition, we determined the usefulness of BAC containing sericin for the preparation of anti-glaucoma eye drops. In studies to evaluate the effects of BAC on corneal wound healing, the selection of the experimental animal is very important. The rat debrided corneal epithelium model has been used in studies aimed at the development of corneal healing drugs 17, 26 , and the mechanism of corneal wound healing in this model is similar to that in humans. Therefore, we used the rat debrided corneal epithelium model to compare corneal damage levels in eyes treated by the instillation of BAC solutions with or without sericin. The corneal wounds of rat eyes instilled with saline showed approximately 51.4 healing at 12 h and 86.2 healing at 24 h after corneal epithelial abrasion, and the wounds were almost completely healed by 36 h after abrasion. We previously reported that the instillation of 1-10 sericin has a potent effect in promoting corneal wound healing in rats 17 . However, the instillation of 0.1 sericin, a very low concentration, was not observed to increase the corneal wound healing rate. The corneal wounds of rat eyes instilled with 0.02 BAC solution containing sericin were 34.8 healed 12 h after corneal epithelium abrasion, but only 6.5 healed in rat eyes instilled with 0.02 BAC solution in the absence of sericin Fig. 1 . In addition, we evaluated the effects of sericin on corneal damage and the antimicrobial activity by BAC using HCE-T cells and E. coli Fig. 2 and 3 . The viability of HCE-T cells treated with BAC solutions containing sericin was higher than that of cells treated with BAC solutions without sericin, and the cell viability increased with increasing sericin concentrations. A 0.005 BAC solution containing 0.1 sericin shows high antimicrobial activity and antimicrobial activity approximately equal to that of TM eye drops with or without sericin. Therefore, these data suggest that the sericin diminishes some of the side effects of BAC. In addition, we investigate that the effect of 0.005 BAC solution containing 0.1 sericin on hemolysis rate using red blood cell RBC of rabbit, which is evaluation model of cell injury. The RBC membrane is broken by the treatment with 0.005 BAC for 20 min, and the hemolysis rate is 98.9 1.6 , n 3 . However, the hemolysis rate by the treatment with 0.005 BAC containing 0.1 sericin for 20 min is 21.5 1.4 , n 3 . From these results, the sericin may prevent the membrane disruption by BAC.
It is important to confirm the usefulness of BAC containing sericin in the preparation of anti-glaucoma eye drops. Glaucoma is characterized by nerve degeneration that results in the disappearance of retinal ganglion cells, visual field loss, excavation of the optic disk, and ophthalmopathy 27, 28 . The major risk factor for glaucoma is elevated IOP, which leads to apoptosis and a loss of retinal ganglion cells 29 . In treating glaucoma, the focus is on the reduction of IOP and the prevention of retinal and optic nerve damage. Anti-glaucoma eye drops are frequently used in clinical treatment, and treatment with anti-glaucoma eye drops must be continued in glaucoma patients even if they cause corneal damage. Recently, anti-glaucoma combination eye drops, such as Xalacom ® latanoprost/TM combination eye drops , Duotrav ® travoprost/TM combination eye drops and Cosopt ® dorzolamide hydrochloride/TM combination eye drops , have been developed. Eye drops containing TM are currently the most prescribed glaucoma medications, and the preservative used in eye drops containing TM is BAC. Therefore, we investigated the corneal wound healing rate following the instillation of commercially available TM eye drops containing saline or sericin using the rat debrided corneal epithelium model. The rate constants for corneal wound healing k H for rat eyes instilled with TM eye drops containing sericin were significantly higher than those of eyes instilled with TM eye drops without sericin Table 2 , and the levels of corneal wound healing of rat eyes instilled with TM eye drops with and without sericin were approximately 79.3 and 65.8 12 h after corneal epithelial abrasion, respectively. These results indicate that TM eye drops without sericin are much more toxic than TM eye drops with sericin. It is known that the surface-active effects of BAC increase the corneal penetration of the main component. Therefore, BAC solutions with or without sericin were examined for their ability to penetrate the cornea and reduce IOP using rabbits. In an in vitro transcorneal penetration experiment, the amount of TM penetrating the cornea increased linearly up to 6 h after the addition of TM eye drops with or without 0.1 sericin into the donor chambers with no significant differences observed between the presence or absence of sericin Table 2 . The instillation of TM eye drops containing 0.1 sericin reduced the enhanced IOP in rabbits in kept in a darkroom, and the IOP reducing effect of TM eye drops containing sericin is similar to that of TM eye drops. These results indicate that the addition of sericin may provide effective therapy for patients requiring long-term anti-glaucoma eye drops. Further studies are needed to elucidate the usefulness of BAC containing sericin for anti-glaucoma eye drop preparations. Therefore, we are now investigating the versatility and antimicrobial activity of sericin using other anti-glaucoma eye drops and organisms.
CONCLUSION
The present study demonstrates that BAC solutions containing sericin are tolerated better on the rat ocular surface than the classic BAC only preservative system. In addition, sericin does not affect the antimicrobial activity of BAC against E. coli or the corneal penetration of TM from commercially available TM eye drops. A BAC plus sericin preservative system may provide effective therapy for glaucoma patients requiring long-term anti-glaucoma agents.
